Screener
Baxter International BAX Reportable Segment — Other
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The source filing: Baxter International’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028962
| (in millions) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Healthcare Systems & Technologies | 66 | 93 |
| Pharmaceuticals | 46 | 63 |
| Total reportable segment operating income | 298 | 400 |
| Other | 11 | 9 |
| Unallocated corporate costs | (12) | (17) |
| Intangible asset amortization expense | (146) | (155) |
| Legal matters | — | (11) |
| Business optimization items | (68) | (45) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Baxter International's reportable segment — other?
- Baxter International (BAX) reported reportable segment — other of $11M in Q1 2026.
- How has Baxter International's reportable segment — other changed year-over-year?
- Baxter International's reportable segment — other increased by 22.2% year-over-year, from $9M to $11M.
- What is the long-term trend for Baxter International's reportable segment — other?
- Over 3 years (2022 to 2025), Baxter International's reportable segment — other has grown at a -17.7% compound annual growth rate (CAGR), from $77M to $43M.
- What does reportable segment — other mean?
- This captures miscellaneous income or expense items that do not fit into the primary operating categories of the business segment. It often includes minor adjustments, non-core operational gains or losses, or residual items that are not material enough to be classified separately.
Ask your AI about Baxter International's reportable segment — other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude